Melky Cabrera’s contract is not evidence that the drug program is broken

49 Comments

As soon as the news broke that Melky Cabrera is signing with the Blue Jays, several people in my Twitter timeline said things to the effect that it must be the case that baseball’s drug testing system is broken if someone fresh off a PED suspension can sign a two-year, $16 million deal. And I get the frustration I suppose, because no one likes to see cheaters prosper, but whatever you think of this deal, it cannot reasonably be interpreted as an indictment of the drug testing system.

Based on his last two seasons, Melky Cabrera was poised to make something like $40 million bucks in free agency. Maybe more. And now, though he is not going to be hurting or anything, he’s going to make less than half that.  Say what you want about the drug testing system, but tens of millions of dollars in lost wages is no small penalty.

Now, that doesn’t mean that Cabrera’s use of PEDs didn’t still somehow help him. I’ll acknowledge that $16 million over two years may still be more than he ever could have got if he never took PEDs.  But we don’t know. We simply have no way of knowing how much of Cabrera’s improvement over the past two years was a function of PEDs and how much of it was natural improvement as he reached an age when most players put up their best years. Maybe he would have turned into the player his potential always suggested he might, in which case he’d still be making a good living. Maybe he wouldn’t have. If anyone claims to know this for sure, they’re making crap up, because it’s unknowable with current science and baseball analytics.

But no matter what amount of advantage he still realized, it’s on Cabrera, human nature and the incentives any person — and any team like the Blue Jays — is subject to, not baseball’s drug program.  Just as no laws, no matter how tough, can eradicate crime, no drug testing program can eradicate cheating. People will still do it from time to time. And when they do, they run the risk of getting caught. And when they get caught, they are punished. As Melky Cabrera was punished, to the tune of tens of millions of dollars.

Still not good enough for you? OK, that’s your right to think so. But know that the only logical conclusion to such thinking is to advocate for a lifetime ban for first time drug users. Because that’s the only thing that would have kept a team from taking a chance on Melky Cabrera like the Blue Jays are.  And while you may disagree, I think such a thing would be way too damn harsh.

Tanner Scheppers leaves Cactus League game with lower core injury

Getty Images
Leave a comment

Rangers’ bullpen candidate Tanner Scheppers left Friday’s Cactus League game with pain in his “lower half,” according to reports by Evan Grant of the Dallas Morning News. The specifics of the right-hander’s injury have yet to be determined, but he was accompanied by the athletic trainer when he exited the game and is scheduled to undergo an MRI on Saturday.

Scheppers, 30, has a long history of elbow and knee injuries. He missed all but 8 2/3 innings of the 2016 season after undergoing a procedure to repair torn articular cartilage in his left knee. While he appeared healthy enough through his first seven appearances this spring, he failed to impress with three runs, five walks and six strikeouts over 7 2/3 innings with the club.

Should Scheppers find himself on the disabled list for another lengthy stay, MLB.com’s T.R. Sullivan speculates that his absence could clear some room in the bullpen for Rule 5 draft pick and fellow righty Mike Hauschild. Hauschild, 27, has dealt seven runs, five walks and 15 strikeouts through 17 1/3 innings in camp.

Report: Jose Ramirez close to four-year extension with Indians

Getty Images
Leave a comment

Yahoo Sports’ Jeff Passan reports that third baseman Jose Ramirez is finalizing a four-year extension with the Indians. The deal is said to be worth north of $30 million, and may crest $50 million if all options are exercised. While the extension won’t take effect until the 2018 season, it guarantees Ramirez a $26 million sum with two options worth $11 and $13 million and will give the Indians control of the infielder through the 2023 season.

Ramirez, 24, is entering his fifth season in the Indians’ organization. He posted career-high numbers during his first full season in the majors, slashing .312/.363/.461 with 11 home runs, 22 stolen bases and 4.8 fWAR in 2016. He’s projected to have a strong follow-up season at the plate and will likely see some time at second base as Jason Kipnis works his way back from a shoulder injury.

Although 2016 only showcased the beginning of Ramirez’s success with the club, FanRag Sports’ Jon Heyman says it’s a standard move for Cleveland to “sign their stars early,” and indicates that Ramirez was rumored to want the deal. Jeff Todd of MLB Trade Rumors adds that the extension will keep Ramirez under club control through three arbitration-eligible years and one year of potential free agency.